R.Kirby Primm

1.2k total citations
19 papers, 928 citations indexed

About

R.Kirby Primm is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, R.Kirby Primm has authored 19 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in R.Kirby Primm's work include Cardiac electrophysiology and arrhythmias (12 papers), Cardiac Arrhythmias and Treatments (4 papers) and Cardiac pacing and defibrillation studies (2 papers). R.Kirby Primm is often cited by papers focused on Cardiac electrophysiology and arrhythmias (12 papers), Cardiac Arrhythmias and Treatments (4 papers) and Cardiac pacing and defibrillation studies (2 papers). R.Kirby Primm collaborates with scholars based in United States. R.Kirby Primm's co-authors include Raymond L. Woosley, Dan M. Roden, John H. Newman, James E. Loyd, John A. Oates, Henry J. Duff, John W. Hammon, G. Wilkinson, Vaughn A. Starnes and Patrick G. Arbogast and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

R.Kirby Primm

19 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.Kirby Primm United States 11 760 300 157 71 47 19 928
J Kuch Poland 9 1.1k 1.4× 158 0.5× 114 0.7× 113 1.6× 42 0.9× 24 1.3k
Edward B. Leahey United States 9 295 0.4× 177 0.6× 77 0.5× 22 0.3× 44 0.9× 13 435
Elizabeth Hand United States 13 330 0.4× 107 0.4× 56 0.4× 140 2.0× 58 1.2× 15 663
Brad S. Burlew United States 14 436 0.6× 154 0.5× 41 0.3× 137 1.9× 37 0.8× 21 735
Reiner Frey Germany 15 659 0.9× 178 0.6× 558 3.6× 62 0.9× 10 0.2× 49 1.0k
Samuel M. Sobol United States 9 345 0.5× 156 0.5× 121 0.8× 41 0.6× 21 0.4× 9 531
T. Fasanella D'amore United States 10 223 0.3× 115 0.4× 53 0.3× 113 1.6× 60 1.3× 11 466
Markus Küng United States 10 158 0.2× 69 0.2× 128 0.8× 49 0.7× 24 0.5× 20 489
A. Pottage United Kingdom 15 271 0.4× 64 0.2× 43 0.3× 82 1.2× 92 2.0× 26 552
Sigrun Unger Germany 13 538 0.7× 157 0.5× 386 2.5× 50 0.7× 6 0.1× 37 891

Countries citing papers authored by R.Kirby Primm

Since Specialization
Citations

This map shows the geographic impact of R.Kirby Primm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.Kirby Primm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.Kirby Primm more than expected).

Fields of papers citing papers by R.Kirby Primm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.Kirby Primm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.Kirby Primm. The network helps show where R.Kirby Primm may publish in the future.

Co-authorship network of co-authors of R.Kirby Primm

This figure shows the co-authorship network connecting the top 25 collaborators of R.Kirby Primm. A scholar is included among the top collaborators of R.Kirby Primm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.Kirby Primm. R.Kirby Primm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Murray, Katherine T., Jeffrey N. Rottman, Patrick G. Arbogast, et al.. (2004). Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm. 1(6). 669–675. 64 indexed citations
2.
Roden, Dan M., John Nadeau, & R.Kirby Primm. (1988). Electrophysiologic and hemodynamic effects of chronic oral therapy with the α2-agonists clonidine and tiamenidine in hypertensive volunteers. Clinical Pharmacology & Therapeutics. 43(6). 648–654. 4 indexed citations
3.
Roden, Dan M., Raymond L. Woosley, & R.Kirby Primm. (1987). Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care. Journal of Critical Care. 2(2). 147–147. 10 indexed citations
4.
Roden, Dan M., Raymond L. Woosley, & R.Kirby Primm. (1986). Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care. American Heart Journal. 111(6). 1088–1093. 372 indexed citations
5.
Duff, Henry J., et al.. (1985). Spectrum of antiarrhythmic response to encainide. The American Journal of Cardiology. 56(13). 887–891. 25 indexed citations
6.
Duff, Henry J., Dan M. Roden, R.Kirby Primm, et al.. (1984). Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.. Journal of Clinical Investigation. 73(2). 539–547. 53 indexed citations
7.
Loyd, James E., R.Kirby Primm, & John H. Newman. (1984). Familial primary pulmonary hypertension: clinical patterns.. PubMed. 129(1). 194–7. 139 indexed citations
8.
Primm, R.Kirby, et al.. (1984). Coronary arterial revascularization in an adult with congenitally corrected transposition. American Heart Journal. 108(3). 598–600. 5 indexed citations
9.
Duff, Henry J., Dan M. Roden, Samuel R. Marney, et al.. (1984). Molecular basis for the antigenicity of lidocaine analogs: Tocainide and mexiletine. American Heart Journal. 107(3). 585–589. 9 indexed citations
10.
Hammon, John W., et al.. (1984). Familial clustering of atrioventricular canal defects. American Heart Journal. 108(1). 175–177. 4 indexed citations
11.
Duff, Henry J., Dan M. Roden, Alastair J.J. Wood, et al.. (1983). Electrophysiologic actions of high plasma concentrations of propranolol in human subjects. Journal of the American College of Cardiology. 2(6). 1134–1140. 42 indexed citations
12.
Duff, Henry J., Dan M. Roden, R.Kirby Primm, John A. Oates, & Raymond L. Woosley. (1983). Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.. Circulation. 67(5). 1124–1128. 113 indexed citations
13.
Starnes, Vaughn A., R.Kirby Primm, Raymond L. Woosley, John A. Oates, & John W. Hammon. (1982). Administration of Prostacyclin Prevents Ventricular Fibrillation Following Coronary Occlusion in Conscious Dogs. Journal of Cardiovascular Pharmacology. 4(5). 765–769. 31 indexed citations
14.
Duff, Henry J., et al.. (1981). Mexiletine for resistant ventricular tachycardia: Comparison with lidocaine and enhancement of efficacy by combination with quinidine. The American Journal of Cardiology. 47. 438–438. 3 indexed citations
15.
Roden, Dan M., Henry J. Duff, R.Kirby Primm, Marvin W. Kronenberg, & Raymond L. Woosley. (1981). Control of ventricular preexcitation and associated arrhythmias by encainide. American Heart Journal. 102(4). 794–797. 7 indexed citations
16.
Primm, R.Kirby, Ferdinand Urthaler, & Thomas N. James. (1980). Selective effects of clonidine on the canine sinus node.. Journal of Pharmacology and Experimental Therapeutics. 214(1). 223–228. 4 indexed citations
17.
Little, William C., R.Kirby Primm, Robert B. Karp, & William P. Hood. (1980). Clotted hemopericardium with the hemodynamic characteristics of constrictive pericarditis. The American Journal of Cardiology. 45(2). 386–388. 16 indexed citations
18.
Primm, R.Kirby, et al.. (1979). Incidence of new pulmonary perfusion defects after routine cardiac catheterization. The American Journal of Cardiology. 43(3). 529–532. 15 indexed citations
19.
Stone, William J., James A. Waldron, J. H. Dixon, R.Kirby Primm, & Robert G. Horn. (1976). Acute Diffuse Interstitial Nephritis Related to Chemotherapy of Tuberculosis. Antimicrobial Agents and Chemotherapy. 10(1). 164–172. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Kuch Breakdown of academic impact, for papers by Edward B. Leahey Breakdown of academic impact, for papers by Elizabeth Hand Breakdown of academic impact, for papers by Brad S. Burlew Breakdown of academic impact, for papers by Reiner Frey Breakdown of academic impact, for papers by Samuel M. Sobol Breakdown of academic impact, for papers by T. Fasanella D'amore Breakdown of academic impact, for papers by Markus Küng Breakdown of academic impact, for papers by A. Pottage Breakdown of academic impact, for papers by Sigrun Unger
Rankless by CCL
2026